Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis
暂无分享,去创建一个
I. Apostolova | W. Brenner | F. Tacke | O. Sansom | A. Kühl | C. Lewis | L. Schomburg | S. Kempa | R. Kramann | W. Faller | M. Stockmann | M. Morkel | S. Jumpertz | T. Cramer | M. Malinowski | Antje Egners | M. Erdem | R. Hughes | S. Neuss | M. Gerling | A. Fragoulis | N. Rohwer | K. T. Warzecha | T. Endermann | C. Zasada | Ines Rudolph | Christin Zasada | K. Warzecha
[1] I. Weissman,et al. HIF-1α activation in myeloid cells accelerates dextran sodium sulfate-induced colitis progression in mice , 2018, Disease Models & Mechanisms.
[2] J. Fandrey,et al. Knockdown of myeloid cell hypoxia-inducible factor-1α ameliorates the acute pathology in DSS-induced colitis , 2017, PloS one.
[3] J. Bergh,et al. An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression , 2017, Cancer cell.
[4] K. Kharbanda,et al. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis , 2017, World journal of gastroenterology.
[5] N. Blüthgen,et al. Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids , 2017, The Journal of cell biology.
[6] A. Jemal,et al. Colorectal cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[7] P. Gascard,et al. Carcinoma-associated fibroblasts: orchestrating the composition of malignancy , 2016, Genes & development.
[8] A. Giaccia,et al. The ever-expanding role of HIF in tumour and stromal biology , 2016, Nature Cell Biology.
[9] T. Wynn,et al. Macrophages in Tissue Repair, Regeneration, and Fibrosis. , 2016, Immunity.
[10] H. Zeh,et al. Targeting hypoxia-mediated mucin 2 production as a therapeutic strategy for mucinous tumors. , 2016, Translational research : the journal of laboratory and clinical medicine.
[11] F. Dazzi,et al. Classification and biology of tumour associated stromal cells. , 2015, Immunology letters.
[12] M. Kohonen-Corish,et al. HIF1α deficiency reduces inflammation in a mouse model of proximal colon cancer , 2015, Disease Models & Mechanisms.
[13] J. Fandrey,et al. Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis , 2015, Mucosal Immunology.
[14] A. Chawla,et al. Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis , 2015, Nature Communications.
[15] T. Luedde,et al. Cyclic adenosine monophosphate–responsive element modulator alpha overexpression impairs function of hepatic myeloid‐derived suppressor cells and aggravates immune‐mediated hepatitis in mice , 2015, Hepatology.
[16] Camille Stephan-Otto Attolini,et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer , 2015, Nature Genetics.
[17] G. Inghirami,et al. Stromal contribution to the colorectal cancer transcriptome , 2015, Nature Genetics.
[18] B. Ebert,et al. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. , 2015, Cell stem cell.
[19] V. Nizet,et al. HIF transcription factors, inflammation, and immunity. , 2014, Immunity.
[20] M. Delorenzi,et al. PROX1 promotes metabolic adaptation and fuels outgrowth of Wnt(high) metastatic colon cancer cells. , 2014, Cell reports.
[21] H. Fiegl,et al. In situ proliferation contributes to accumulation of tumor‐associated macrophages in spontaneous mammary tumors , 2014, European journal of immunology.
[22] S. Ramakrishnan,et al. Activation of HIF-1α does not increase intestinal tumorigenesis. , 2014, American journal of physiology. Gastrointestinal and liver physiology.
[23] Umar Mahmood,et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. , 2014, Cancer cell.
[24] Stephen A. Sastra,et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. , 2014, Cancer cell.
[25] S. Sivanand,et al. Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancer. , 2014, Carcinogenesis.
[26] Dean Sheppard,et al. TGF-β activation and function in immunity. , 2014, Annual review of immunology.
[27] David Artis,et al. Intestinal epithelial cells: regulators of barrier function and immune homeostasis , 2014, Nature Reviews Immunology.
[28] C. Köhne. Successes and limitations of targeted cancer therapy in colon cancer. , 2014, Progress in tumor research.
[29] J. Greenson,et al. Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice. , 2013, Gastroenterology.
[30] R. Schwabe,et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice , 2013, Hepatology.
[31] O. Lee,et al. Hypoxia-Induced Secretion of TGF-β1 in Mesenchymal Stem Cell Promotes Breast Cancer Cell Progression , 2013, Cell transplantation.
[32] G. Semenza,et al. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. , 2013, The Journal of clinical investigation.
[33] P. Allavena,et al. Tumor-associated macrophages: functional diversity, clinical significance, and open questions , 2013, Seminars in Immunopathology.
[34] D. Threadgill,et al. Tumor fibroblast-derived epiregulin promotes growth of colitis-associated neoplasms through ERK. , 2013, The Journal of clinical investigation.
[35] Jonathan B. Mitchem,et al. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. , 2013, Cancer research.
[36] B. Herrmann,et al. Wnt and BMP signals control intestinal adenoma cell fates , 2012, International journal of cancer.
[37] M. Neurath,et al. Interleukin-6 - A Key Regulator of Colorectal Cancer Development , 2012, International journal of biological sciences.
[38] P. Fraker,et al. Enhanced production of early lineages of monocytic and granulocytic cells in mice with colitis , 2012, Proceedings of the National Academy of Sciences.
[39] Michael C. Ostrowski,et al. Loss of fibroblast HIF-1α accelerates tumorigenesis. , 2012, Cancer research.
[40] G. Semenza. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. , 2012, Trends in pharmacological sciences.
[41] Hans Clevers,et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. , 2011, Gastroenterology.
[42] R. Gomer,et al. Improved serum-free culture conditions for spleen-derived murine fibrocytes. , 2010, Journal of immunological methods.
[43] M. Celeste Simon,et al. O2 regulates stem cells through Wnt/β-catenin signalling , 2010, Nature Cell Biology.
[44] L. Coussens,et al. Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. , 2010, Cancer research.
[45] Luke Barron,et al. Macrophages: Master Regulators of Inflammation and Fibrosis , 2010, Seminars in liver disease.
[46] J. Meyerhardt,et al. HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. , 2010, The American journal of pathology.
[47] Alberto Mantovani,et al. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. , 2010, Current opinion in immunology.
[48] A. Hisatsune,et al. Hypoxia enhances MUC1 expression in a lung adenocarcinoma cell line. , 2009, Biochemical and biophysical research communications.
[49] Hirotoshi Kikuchi,et al. HIF‐1α and HIF‐2α have divergent roles in colon cancer , 2009, International journal of cancer.
[50] Na Zhang,et al. Deletion of Vascular Endothelial Growth Factor in myeloid cells accelerates tumorigenesis , 2008, Nature.
[51] K. Morimura,et al. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. , 2008, Gastroenterology.
[52] S. Colgan,et al. Mucosal protection by hypoxia‐inducible factor (HIF) prolyl hydroxylase inhibition , 2008 .
[53] H. Clevers,et al. Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.
[54] L. Ricci-Vitiani,et al. Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.
[55] S. Colgan,et al. Selective induction of mucin‐3 by hypoxia in intestinal epithelia , 2006, Journal of cellular biochemistry.
[56] D. Qualtrough,et al. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. , 2006, Cancer research.
[57] C. Cherbut,et al. MUC Genes Are Differently Expressed During Onset and Maintenance of Inflammation in Dextran Sodium Sulfate-Treated Mice , 2006, Digestive Diseases and Sciences.
[58] Manish Gala,et al. Induction of interleukin-8 preserves the angiogenic response in HIF-1α–deficient colon cancer cells , 2005, Nature Medicine.
[59] M. Tachibana,et al. Prognostic Impact of Hypoxia-Inducible Factors 1α and 2α in Colorectal Cancer Patients , 2004, Clinical Cancer Research.
[60] John E Tomaszewski,et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. , 2004, The Journal of clinical investigation.
[61] K. Kinzler,et al. Cancer genes and the pathways they control , 2004, Nature Medicine.
[62] Ruslan Medzhitov,et al. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.
[63] Ian P Newton,et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. , 2004, Genes & development.
[64] R. Jaenisch,et al. HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation , 2003, Cell.
[65] G. Semenza,et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. , 2003, Cancer research.
[66] D. Gumucio,et al. cis Elements of the Villin Gene Control Expression in Restricted Domains of the Vertical (Crypt) and Horizontal (Duodenum, Cecum) Axes of the Intestine* , 2002, The Journal of Biological Chemistry.
[67] J. M. Arbeit,et al. Hypoxia-inducible Factor-1α Is a Positive Factor in Solid Tumor Growth , 2000 .
[68] D A Hilton,et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.
[69] K. Webster,et al. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. , 1998, Biochemical and biophysical research communications.
[70] J. Sundberg,et al. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[71] T. Ohkusa,et al. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. , 1996, Gut.
[72] R. Bucala,et al. Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair , 1994, Molecular medicine.
[73] H. Cooper,et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[74] K. Kinzler,et al. Erratum: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene , 1992, Science.
[75] R. Ross,et al. WOUND HEALING AND COLLAGEN FORMATION , 1961, The Journal of biophysical and biochemical cytology.
[76] J. Cell. An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression , 2017 .
[77] Min Huang,et al. Molecularly targeted cancer therapy: some lessons from the past decade. , 2014, Trends in pharmacological sciences.
[78] C. Rao,et al. The role of inflammation in colon cancer. , 2014, Advances in experimental medicine and biology.
[79] G. R. van den Brink,et al. Role of mast cells in colorectal cancer development, the jury is still out. , 2012, Biochimica et biophysica acta.
[80] E. Cummins,et al. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. , 2008, Gastroenterology.
[81] M. Tachibana,et al. Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.
[82] R. Jaenisch,et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. , 2003, Cell.
[83] J. M. Arbeit,et al. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. , 2000, Cancer research.